4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Rezolute, Inc. (RZLT) operates in the Biotechnology industry and is headquartered in Redwood City, United States with about 68 employees. Its market capitalization is roughly $494 million. In the fiscal year ended 2025-06-30, RZLT reported $0M in revenue and ($74M) in net income.
Rezolute, Inc., a late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in the United States.
Interactive charts & full statements →
| Income statement | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($80M) | ($70M) | ($56M) | ($42M) |
| Net Income | ($74M) | ($68M) | ($52M) | ($41M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($17M) | ($24M) | ($20M) | ($26M) | ($20M) | — |
| Net Income | ($16M) | ($23M) | ($18M) | ($24M) | ($19M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Total Assets | $176M | $133M | $124M | $152M |
| Total Liabilities | $13M | $12M | $8M | $3M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive RZLT viewer.
About TickerBase · Data methodology & sources